MBX Biosciences (MBX) Institutional Ownership $10.75 -0.54 (-4.78%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$11.18 +0.43 (+3.95%) As of 06/27/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for MBX Biosciences (NYSE:MBX)Number ofInstitutional Buyers(last 12 months)49TotalInstitutional Inflows(last 12 months)$429.77MNumber ofInstitutional Sellers(last 12 months)8TotalInstitutional Outflows(last 12 months)$8.32M Get MBX Insider Trade Alerts Want to know when executives and insiders are buying or selling MBX Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MBX Institutional Buying and Selling by Quarter MBX Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails6/27/2025 Goldman Sachs Group Inc.15,168$112K0.0%-56.4%0.045% 5/16/2025 Woodline Partners LP877,461$6.48M0.0%+44.1%2.625% 5/16/2025 Exome Asset Management LLC133,113$982K0.8%N/A0.398% 5/16/2025 Goldman Sachs Group Inc.15,168$112K0.0%-56.4%0.045% 5/16/2025 Parkman Healthcare Partners LLC328,323$2.42M0.3%+93.1%0.982% 5/15/2025 MPM Bioimpact LLC1,132,950$8.36M1.4%N/A3.390% 5/15/2025 Driehaus Capital Management LLC1,579,207$11.66M0.1%-0.2%4.725% 5/14/2025 Affinity Asset Advisors LLC175,000$1.29M0.1%N/A0.524% 5/14/2025 Walleye Capital LLC32,490$240K0.0%N/A0.097% 5/14/2025 Jump Financial LLC28,996$214K0.0%N/A0.087% Get the Latest News and Ratings for MBX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MBX Biosciences and its competitors with MarketBeat's FREE daily newsletter. 5/14/2025 Wellington Management Group LLP2,638,521$19.47M0.0%-9.3%7.894% 5/13/2025 Wealthedge Investment Advisors LLC11,864$88K0.0%N/A0.035% 5/12/2025 Nuveen LLC14,471$107K0.0%N/A0.043% 5/12/2025 Koa Wealth Management LLC19,396$143K0.1%N/A0.058% 5/9/2025 Deutsche Bank AG8,762$65K0.0%+102.0%0.026% 5/9/2025 Charles Schwab Investment Management Inc.94,546$698K0.0%+1.3%0.283% 5/7/2025 TD Asset Management Inc151,504$1.12M0.0%+313.9%0.453% 5/1/2025 New York State Common Retirement Fund4,300$32K0.0%N/A0.013% 4/30/2025 Alps Advisors Inc.26,034$192K0.0%-3.6%0.078% 4/28/2025 Aaron Wealth Advisors LLC50,000$369K0.0%N/A0.150% 3/24/2025 Wellington Management Group LLP2,909,639$52.99M0.0%-1.0%8.705% 2/17/2025 Woodline Partners LP608,721$11.22M0.1%+17.1%1.821% 2/17/2025 Parkman Healthcare Partners LLC170,000$3.13M0.4%N/A0.509% 2/17/2025Nuveen Asset Management LLC14,471$267K0.0%N/A0.043% 2/17/2025 Millennium Management LLC333,642$6.15M0.0%-24.2%0.998% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.6,335$117K0.0%N/A0.019% 2/17/2025 Deutsche Bank AG4,338$80K0.0%N/A0.013% 2/17/2025 Driehaus Capital Management LLC1,581,760$29.15M0.2%+61.2%4.733% 2/17/2025 Citadel Advisors LLC220,330$4.06M0.0%+62.5%0.659% 2/17/2025 Bank of America Corp DE16,059$296K0.0%N/A0.048% 2/17/2025 BNP Paribas Financial Markets1,486$27K0.0%N/A0.004% 2/17/2025 Alyeska Investment Group L.P.174,700$3.22M0.0%-22.4%0.523% 2/14/2025 Schonfeld Strategic Advisors LLC71,500$1.32M0.0%N/A0.214% 2/14/2025 Northern Trust Corp90,682$1.67M0.0%N/A0.271% 2/14/2025 The Manufacturers Life Insurance Company49,675$916K0.0%+7.5%0.149% 2/14/2025 Virtus ETF Advisers LLC3,468$64K0.0%N/A0.010% 2/14/2025 Price T Rowe Associates Inc. MD1,161,527$21.41M0.0%-2.6%3.476% 2/14/2025 MetLife Investment Management LLC7,230$133K0.0%N/A0.022% 2/13/2025 Marshall Wace LLP25,900$477K0.0%+115.8%0.077% 2/13/2025 Wells Fargo & Company MN5,844$108K0.0%N/A0.017% The Trump Dump is starting; Get out of stocks now? (Ad)The first 365 days of the Trump presidency… Will be the best time to get rich in American history.If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a2/12/2025 Geode Capital Management LLC265,703$4.90M0.0%+1,093.2%0.795% 2/12/2025 Franklin Resources Inc.369,300$6.81M0.0%-17.9%1.105% 2/12/2025 Wellington Management Group LLP2,909,639$52.99M0.0%-1.0%8.706% 2/12/2025 Norges Bank25,000$461K0.0%N/A0.075% 2/12/2025 BIT Capital GmbH12,743$235K0.0%N/A0.038% 2/12/2025 JPMorgan Chase & Co.9,106$168K0.0%N/A0.027% 2/11/2025 Corebridge Financial Inc.5,593$103K0.0%N/A0.017% 2/11/2025 Platinum Investment Management Ltd.162,090$2.99M0.2%+8.1%0.485% 2/6/2025 Charles Schwab Investment Management Inc.93,311$1.72M0.0%N/A0.279% 2/4/2025 Bank of New York Mellon Corp23,914$441K0.0%N/A0.072% 1/30/2025 Rhumbline Advisers9,472$175K0.0%N/A0.028% 11/27/2024 Franklin Resources Inc.450,000$11.69M0.0%N/A1.347% 11/19/2024 Barclays PLC16,400$426K0.0%N/A0.049% 11/18/2024 Teachers Retirement System of The State of Kentucky26,708$694K0.0%N/A0.080% 11/16/2024 Geode Capital Management LLC22,269$579K0.0%N/A0.067% 11/15/2024 Frazier Life Sciences Management L.P.5,985,347$155.50M6.2%N/A17.909% 11/15/2024 Barclays PLC16,400$426K0.0%N/A0.049% 11/15/2024 Jane Street Group LLC26,570$690K0.0%N/A0.080% 11/15/2024 Wellington Management Group LLP2,937,853$74.26M0.0%N/A8.791% 11/15/2024 Soros Fund Management LLC30,000$779K0.0%N/A0.090% 11/15/2024 RA Capital Management L.P.1,511,334$39.26M0.5%N/A4.522% 11/15/2024 Point72 DIFC Ltd24,011$624K0.0%N/A0.072% 11/15/2024 Point72 Asset Management L.P.15,600$405K0.0%N/A0.047% 11/15/2024 Maven Securities LTD50,000$1.30M0.0%N/A0.150% 11/15/2024 Point72 Asia Singapore Pte. Ltd.10,706$278K0.1%N/A0.032% 11/14/2024 NEA Management Company LLC3,614,486$93.90M5.1%N/A10.816% 11/13/2024 The Manufacturers Life Insurance Company46,194$1.20M0.0%N/A0.138% (Data available from 1/1/2016 forward) MBX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MBX shares? During the previous two years, 54 institutional investors and hedge funds held shares of MBX Biosciences. The most heavily invested institutionals were Frazier Life Sciences Management L.P. ($155.50M), NEA Management Company LLC ($93.90M), RA Capital Management L.P. ($39.26M), Price T Rowe Associates Inc. MD ($21.41M), Wellington Management Group LLP ($19.47M), Driehaus Capital Management LLC ($11.66M), and MPM Bioimpact LLC ($8.36M).Learn more on MBX Biosciences' institutional investors. Which institutional investors have been buying MBX Biosciences' stock? Of the 49 institutional investors that purchased MBX Biosciences' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Frazier Life Sciences Management L.P. ($5.99M), NEA Management Company LLC ($3.61M), Wellington Management Group LLP ($2.94M), RA Capital Management L.P. ($1.51M), MPM Bioimpact LLC ($1.13M), Driehaus Capital Management LLC ($600.44K), and Franklin Resources Inc. ($450K). How much institutional buying is happening at MBX Biosciences? Institutional investors have bought a total of 18,551,747 shares in the last 24 months. This purchase volume represents approximately $429.77M in transactions. Which of MBX Biosciences' major shareholders have been selling company stock? The following institutional investors have sold MBX Biosciences stock in the last 24 months: Wellington Management Group LLP ($327.55K), Millennium Management LLC ($106.77K), Franklin Resources Inc. ($80.70K), Alyeska Investment Group L.P. ($50.30K), Goldman Sachs Group Inc. ($39.32K), Price T Rowe Associates Inc. MD ($31.41K), and Driehaus Capital Management LLC ($2.55K). How much institutional selling is happening at MBX Biosciences? Institutional investors have sold a total of 639,583 shares in the last 24 months. This volume of shares sold represents approximately $8.32M in transactions. Related Companies Travere Therapeutics Institutional Ownership Mesoblast Institutional Ownership Structure Therapeutics Institutional Ownership CureVac Institutional Ownership Calliditas Therapeutics AB (publ) Institutional Ownership Dyne Therapeutics Institutional Ownership Amphastar Pharmaceuticals Institutional Ownership CorMedix Institutional Ownership Aurinia Pharmaceuticals Institutional Ownership AbCellera Biologics Institutional Ownership This page (NYSE:MBX) was last updated on 6/30/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… And it's all thanks to President Trump. His ...InvestorPlace | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored“Trump’s 24-Hour Profit Windows” revealedTrading legend Larry Benedict has discovered a repeating surge of $240 billion (and more)... Flowing into a...Brownstone Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MBX Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MBX Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
